Oct 2026· Frontiers in Microbiology· 0 citations· 129 references
TL;DR
It is concluded that multi-strain probiotics reduce severe NEC and all-cause mortality, but evidence for LOS is inconsistent and neurodevelopmental benefit remains unproven, and routine universal use is not justified.
Abstract
Preterm infants are at a heightened risk for gut dysbiosis, a condition characterized by reduced microbial diversity, delayed colonization by beneficial commensals such as
Bifidobacterium
, and overgrowth of opportunistic pathogens. This disrupted microbial ecosystem is intricately linked to the pathogenesis of life-threatening conditions, including necrotizing enterocolitis (NEC), late-onset sepsis (LOS), and feeding intolerance, and is also implicated in long-term neurodevelopmental and respiratory outcomes. Probiotic supplementation has emerged as a prominent strategy to shift the microbiota toward a more eubiotic-like composition and mitigate these risks. This narrative review synthesizes evidence from a wide range of randomized controlled trials, observational studies, systematic reviews, and meta-analyses to evaluate the clinical efficacy and microbiological impact of probiotics in preterm populations. The evidence indicates that probiotic interventions, particularly specific multi-strain formulations containing well-defined
Lactobacillus
and
Bifidobacterium
strains, are associated with significant reductions in the incidence of severe NEC (risk ratio 0.38–0.57) and all-cause mortality (risk ratio 0.69). However, their effect on preventing LOS and reducing colonization by multidrug-resistant organisms is less consistent. Probiotics consistently enhance the intestinal abundance of beneficial bacteria, modulate metabolic profiles, and reduce markers of intestinal inflammation. However, effects are strain-specific and cannot be extrapolated across products; future trials should report full strain identity, dose, viability, and product composition. Emerging evidence also suggests a potential role for probiotics in influencing immune cell development and the gut-brain axis, with implications for neurodevelopment and seizure prevention, though these findings are preliminary. This review also addresses critical challenges, including the considerable heterogeneity in study designs, probiotic strains, and clinical protocols, safety concerns in extremely low-birth-weight infants, and the methodological issues related to product quality and taxonomic identification. We conclude that multi-strain probiotics reduce severe NEC and all-cause mortality, but evidence for LOS is inconsistent and neurodevelopmental benefit remains unproven. Routine universal use is therefore not justified; translation requires product-specific trials and regulatory-grade quality control.
Premature births remain a significant global health concern, contributing to high mortality rates among children under five. Preterm newborns (<37 weeks' gestation) encounter considerable health issues due to their underdeveloped organ systems and gut microbiota. These vulnerabilities result in major complications, inc...
Significant heterogeneity in strains, dosing, and study design limits generalizability of probiotic efficacy in pediatrics, and standardized RCTs and precision microbiome approaches are required.
Smriti Mishra, S. Saxena· La Clinica pediatrica· 0 citations
The findings suggest that early-life factors, including antibiotic exposure, prematurity, complex clinical conditions, and surgical interventions, may substantially affect microbial colonization, and alterations may be associated with an increased risk of complications and systemic inflammation.
Marsiglia Riccardo, D. D. De Rose, Panebianco Stefania et al.· Frontiers in Medicine· 0 citations
Symptomatic Uncomplicated Diverticular Disease (SUDD) of the colon represents one of the most common gastrointestinal disorders in Western countries, with prevalence increasing significantly with age. Among its clinical manifestations, SUDD is characterized by recurrent abdominal pain, bloating, and alterations in bowe...
Giovanni Tomasello, Francesco Alamia, Riccardo Chiodo et al.· Journal of Biological Resear...· 0 citations
Metabolic syndrome (MetS), characterized by obesity, insulin resistance, dyslipidemia, and hypertension, is closely associated with gut microbiota dysbiosis. Increasing evidence suggests that probiotics may restore microbial balance and alleviate metabolic disturbances. This study reviews the mechanistic roles of probi...
The gut microbiome is increasingly recognized as a critical determinant of gastrointestinal health and disease, and interactions between probiotic microorganisms and their bioactive metabolites, known as postbiotics, play a fundamental role in maintaining colorectal homeostasis. Recent evidence suggests that disruption...
Swati Mishra, P. Singh, P. S. Krishna et al.· International Surgery Journa...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.